Tag: 4basecare
4baseCare signs MoU with Maharashtra govt to establish Centre of Excellence...
The MoU signing took place at PULSE 2026, India’s leading Healthcare and Medical Education Summit, that was held in Mumbai recently
4baseCare partners with France-based Owkin to advance inclusive cancer research
Through this collaboration, the two companies will work together to convert fragmented cancer care data into AI-ready intelligence
4baseCare partners with Caritas Hospitals to bring personalised cancer care to...
Through this collaboration, doctors can use genetic testing to better understand each patient’s cancer and choose treatments that are more targeted, effective, and easier
4baseCare raises Rs 90 Cr in Series B first close led...
The funding will be used towards expansion into new geographies and to scale its AI powered precision oncology platform, OncoTwin
4baseCare inaugurates new genomics lab, unveils global cancer diversity atlas
The new genomics lab in Bengaluru will offer advanced genomic testing solutions including comprehensive gene panels, whole exome sequencing, and transcriptome analysis
AIIMS Jammu collaborates with 4baseCare to launch Centre for Advanced Genomics...
This powerful capability enables clinicians to design highly personalized, targeted treatment plans tailored to each patient’s unique molecular profile
LuNGS Alliance launches free lung NGS biomarker testing for lung cancer...
An Initiative by Cancer Research and Statistic Foundation, Supported by AstraZeneca, Pfizer & Roche and lab partner 4baseCare
4baseCare secures CAP accreditation for its genomics lab in Dubai
This accreditation ensures that cancer patients in the UAE now have access to world-class genomic profiling locally
AIIMS Jammu partners 4baseCare to host Precision Oncology Expert Meet
POEM-2025 hosted a series of panel discussions, case-based studies, and expert insights focused on leveraging advanced technology for better patient outcomes
AIIMS Jammu & 4baseCare sign MoU to launch Centre for Advanced...
The centre aims to redefine cancer care by focusing on targeted, biomarker-driven therapies